melatonin has been researched along with Weight Gain in 44 studies
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We aimed to evaluate melatonin effectiveness in weight gain reduction following olanzapine use for 11-17-year-old bipolar disorder patients." | 9.24 | Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. ( Akhondzadeh, S; Mohammadi, MR; Mostafavi, SA; Solhi, M, 2017) |
| " Melatonin, liraglutide, and naltrexone/bupropion are examples of drugs with different mechanisms of action that have favorable effects on obesity or medication-related weight gain." | 8.91 | Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain. ( Howland, RH, 2015) |
| "To explore the effects of Kaixin Powder (, KXP) on melatonin receptor (MR) expression and (125)I-Mel binding affinity in a depression rat model." | 7.81 | Effects of Kaixin Powder on melatonin receptor expression and (125)I-Mel binding affinity in a rat model of depression. ( Cai, C; Gao, C; Guan, JH; Guo, J; Huang, YL; Liang, XB; Qian, LQ; Zhao, GP, 2015) |
| "The results show that exogenous melatonin reduces body weight gain without having marked effects on metabolism." | 7.79 | Melatonin reduces body weight gain and increases nocturnal activity in male Wistar rats. ( Barriga, C; Delgado-Adámez, J; Paredes, SD; Pariente, JA; Rodríguez, AB; Terrón, MP, 2013) |
| "The atypical antipsychotic drug olanzapine increases body weight and visceral adiposity in schizophrenia." | 7.74 | Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats. ( Burke, BL; Crites, NJ; Raskind, MA; Rasmussen, DD; Tapp, AM, 2007) |
| "Melatonin is involved in the regulation of seasonal obesity in various species, including some rodents." | 7.72 | Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. ( Bros, A; Casteilla, L; Delagrange, P; Desbazeille, M; Louche, K; Pénicaud, L; Prunet-Marcassus, B; Renard, P, 2003) |
| "Melatonin is a sleep-related neurohormone and affected by the circadian rhythm and light/dark cycles." | 5.72 | Melatonin protects against body weight gain induced by sleep deprivation in mice. ( Hu, S; Liu, X; Wang, Y; Wei, S; Zhang, R, 2022) |
| "Melatonin treatment significantly attenuated body weight gain at 23 weeks (control; 57." | 5.62 | Long-term melatonin treatment attenuates body weight gain with aging in female mice. ( Doi-Tanaka, Y; Kawamoto-Jozaki, M; Maekawa, R; Mihara, Y; Sato, S; Shirafuta, Y; Sugino, N; Takagi, H; Taketani, T; Tamura, H; Tamura, I, 2021) |
| "Excess weight and obesity are severe public health threats worldwide." | 5.46 | Melatonin prevents obesity through modulation of gut microbiota in mice. ( Hong, F; Jia, L; Jin, X; Wang, J; Wang, S; Xu, P; Xue, T; Zhai, Y, 2017) |
| "We aimed to evaluate melatonin effectiveness in weight gain reduction following olanzapine use for 11-17-year-old bipolar disorder patients." | 5.24 | Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. ( Akhondzadeh, S; Mohammadi, MR; Mostafavi, SA; Solhi, M, 2017) |
| "There is low-certainty evidence to suggest that metformin may be effective in preventing weight gain." | 5.22 | Pharmacological interventions for prevention of weight gain in people with schizophrenia. ( Agarwal, SM; Ahsan, ZA; Cohn, T; Duncan, MJ; Faulkner, GEJ; Hahn, M; Lockwood, JT; Remington, G; Stogios, N; Takeuchi, H; Taylor, VH, 2022) |
| " The aim of this study was to investigate whether melatonin and histidine, alone or in combination, could produce weight loss, meanwhile improve the cognitive processes." | 4.31 | Nano-melatonin and-histidine modulate adipokines and neurotransmitters to improve cognition in HFD-fed rats: A formula to study. ( Abo-ElMatty, DM; Farid, O; Ghattas, MH; Hegazy, HA; Omar, NN; Saleh, S, 2023) |
| "To explore the effects of Kaixin Powder (, KXP) on melatonin receptor (MR) expression and (125)I-Mel binding affinity in a depression rat model." | 3.81 | Effects of Kaixin Powder on melatonin receptor expression and (125)I-Mel binding affinity in a rat model of depression. ( Cai, C; Gao, C; Guan, JH; Guo, J; Huang, YL; Liang, XB; Qian, LQ; Zhao, GP, 2015) |
| "The atypical antipsychotic drug olanzapine increases body weight and visceral adiposity in schizophrenia." | 3.74 | Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats. ( Burke, BL; Crites, NJ; Raskind, MA; Rasmussen, DD; Tapp, AM, 2007) |
| "Melatonin is involved in the regulation of seasonal obesity in various species, including some rodents." | 3.72 | Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. ( Bros, A; Casteilla, L; Delagrange, P; Desbazeille, M; Louche, K; Pénicaud, L; Prunet-Marcassus, B; Renard, P, 2003) |
| "Melatonin is a pineal hormone that plays an important role as an endogenous synchronizer of circadian rhythms and energy metabolism." | 3.11 | The Effect of Exogenous Melatonin on Eating Habits of Female Night Workers with Excessive Weight. ( Cipolla-Neto, J; Crispim, CA; de Castro Moreno, CR; Marqueze, EC; Nogueira, LFR, 2022) |
| "Body weight gain was analyzed, as the main indicator of stability and the main criteria for discharge in preterm infants born at 31." | 2.79 | A light/dark cycle in the NICU accelerates body weight gain and shortens time to discharge in preterm infants. ( Angeles-Castellanos, M; Escobar, C; Maya-Barrios, JA; Rojas-Granados, A; Torres-Narváez, P; Vásquez-Ruiz, S; Vega-Martínez, BR, 2014) |
| "Obstructive sleep apnea is the most prevalent type of obesity-related sleep disorder that lead to an increased risk for numerous chronic health conditions." | 2.61 | Obesity and sleep disturbance: the chicken or the egg? ( Annunziata, G; Barrea, L; Colao, A; Di Somma, C; Laudisio, D; Muscogiuri, G; Savastano, S, 2019) |
| "Melatonin was beneficial in lowering blood pressure among bipolar disorder patients; this blood pressure-lowering effect was not prominent among schizophrenic patients." | 2.53 | The role of melatonin and melatonin agonists in counteracting antipsychotic-induced metabolic side effects: a systematic review. ( Bahk, WM; Wang, HR; Woo, YS, 2016) |
| "The consequences of chronic sleep deprivation on energy expenditure have not been fully explored." | 2.47 | Chronic sleep deprivation and seasonality: implications for the obesity epidemic. ( Cizza, G; de Jonge, L; Galli, G; Requena, M, 2011) |
| "Melatonin is a sleep-related neurohormone and affected by the circadian rhythm and light/dark cycles." | 1.72 | Melatonin protects against body weight gain induced by sleep deprivation in mice. ( Hu, S; Liu, X; Wang, Y; Wei, S; Zhang, R, 2022) |
| "Melatonin is a chronobiotic substance that plays a main role in stabilizing bodily rhythm and has shown beneficial effects in protecting against obesity." | 1.56 | Melatonin Orchestrates Lipid Homeostasis through the Hepatointestinal Circadian Clock and Microbiota during Constant Light Exposure. ( Guo, Y; Hong, F; Jia, L; Li, L; Pan, S; Qiao, X; Wang, J; Xu, P; Xue, T; Zhai, Y, 2020) |
| "Melatonin (MLT) plays a role in preserving bone health, a function that may depend on homeostatic effects on both mature osteoblasts and mesenchymal stem cells (MSCs) of the bone tissue." | 1.51 | Melatonin prevents cadmium-induced bone damage: First evidence on an improved osteogenic/adipogenic differentiation balance of mesenchymal stem cells as underlying mechanism. ( Bartolini, D; Galli, F; Kechiche, S; Knani, L; Messaoudi, I; Moretti, M; Murdolo, G; Reiter, RJ; Tortoioli, C, 2019) |
| "Excess weight and obesity are severe public health threats worldwide." | 1.46 | Melatonin prevents obesity through modulation of gut microbiota in mice. ( Hong, F; Jia, L; Jin, X; Wang, J; Wang, S; Xu, P; Xue, T; Zhai, Y, 2017) |
| "Food intake and weight gain are known to be affected by stress." | 1.36 | The weight gain response to stress during adulthood is conditioned by both sex and prenatal stress exposure. ( Argente, J; Azcoitia, I; Calmarza-Font, I; Chowen, JA; Diz-Chaves, Y; Frago, LM; García-Cáceres, C; Garcia-Segura, LM; Lagunas, N, 2010) |
| "Melatonin treatment did not alter cumulative food consumption." | 1.32 | Melatonin effect on rat body weight regulation in response to high-fat diet at middle age. ( Green, JN; Puchalski, SS; Rasmussen, DD, 2003) |
| "Melatonin treatment was found to reduce plasma, liver cholesterol and DC levels as well as liver triglyceride levels in hypercholesterolemic mice." | 1.32 | Melatonin reduces cholesterol accumulation and prooxidant state induced by high cholesterol diet in the plasma, the liver and probably in the aorta of C57BL/6J mice. ( Balkan, J; Cevikbaş, U; Keyer-Uysal, M; Sener, G; Uysal, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (11.36) | 18.2507 |
| 2000's | 11 (25.00) | 29.6817 |
| 2010's | 19 (43.18) | 24.3611 |
| 2020's | 9 (20.45) | 2.80 |
| Authors | Studies |
|---|---|
| Nogueira, LFR | 1 |
| Crispim, CA | 1 |
| Cipolla-Neto, J | 1 |
| de Castro Moreno, CR | 1 |
| Marqueze, EC | 1 |
| Hu, S | 1 |
| Liu, X | 1 |
| Wang, Y | 1 |
| Zhang, R | 1 |
| Wei, S | 1 |
| Agarwal, SM | 1 |
| Stogios, N | 1 |
| Ahsan, ZA | 1 |
| Lockwood, JT | 1 |
| Duncan, MJ | 1 |
| Takeuchi, H | 1 |
| Cohn, T | 1 |
| Taylor, VH | 1 |
| Remington, G | 1 |
| Faulkner, GEJ | 1 |
| Hahn, M | 1 |
| Hegazy, HA | 1 |
| Abo-ElMatty, DM | 1 |
| Farid, O | 1 |
| Saleh, S | 1 |
| Ghattas, MH | 1 |
| Omar, NN | 1 |
| Al-Obeidi, BNR | 1 |
| Mansoor, AR | 1 |
| Avilés, R | 1 |
| Delgadillo, JA | 1 |
| Flores, JA | 1 |
| Duarte, G | 1 |
| Vielma, J | 1 |
| Flores, MJ | 1 |
| Petrovski, K | 1 |
| Zarazaga, LA | 1 |
| Hernández, H | 1 |
| Sinkalu, VO | 1 |
| Ayo, JO | 1 |
| Hambolu, JO | 1 |
| Adelaiye, AB | 1 |
| Zakari, FO | 1 |
| Aluwong, T | 1 |
| Hong, F | 2 |
| Pan, S | 1 |
| Xu, P | 2 |
| Xue, T | 2 |
| Wang, J | 2 |
| Guo, Y | 1 |
| Jia, L | 2 |
| Qiao, X | 1 |
| Li, L | 1 |
| Zhai, Y | 2 |
| Tung, YT | 1 |
| Chiang, PC | 1 |
| Chen, YL | 1 |
| Chien, YW | 1 |
| Tamura, I | 1 |
| Tamura, H | 1 |
| Kawamoto-Jozaki, M | 1 |
| Doi-Tanaka, Y | 1 |
| Takagi, H | 1 |
| Shirafuta, Y | 1 |
| Mihara, Y | 1 |
| Maekawa, R | 1 |
| Taketani, T | 1 |
| Sato, S | 1 |
| Sugino, N | 1 |
| Mostafavi, SA | 1 |
| Solhi, M | 1 |
| Mohammadi, MR | 1 |
| Akhondzadeh, S | 1 |
| McHill, AW | 2 |
| Phillips, AJ | 1 |
| Czeisler, CA | 1 |
| Keating, L | 1 |
| Yee, K | 1 |
| Barger, LK | 1 |
| Garaulet, M | 1 |
| Scheer, FA | 1 |
| Klerman, EB | 1 |
| Zapp, AA | 1 |
| Fischer, EC | 1 |
| Deuschle, M | 1 |
| Muscogiuri, G | 1 |
| Barrea, L | 1 |
| Annunziata, G | 1 |
| Di Somma, C | 1 |
| Laudisio, D | 1 |
| Colao, A | 1 |
| Savastano, S | 1 |
| Khan, NA | 1 |
| Sharma, J | 1 |
| Chakrabarti, R | 1 |
| Knani, L | 1 |
| Bartolini, D | 1 |
| Kechiche, S | 1 |
| Tortoioli, C | 1 |
| Murdolo, G | 1 |
| Moretti, M | 1 |
| Messaoudi, I | 1 |
| Reiter, RJ | 1 |
| Galli, F | 1 |
| Terrón, MP | 1 |
| Delgado-Adámez, J | 1 |
| Pariente, JA | 1 |
| Barriga, C | 1 |
| Paredes, SD | 1 |
| Rodríguez, AB | 1 |
| Vásquez-Ruiz, S | 1 |
| Maya-Barrios, JA | 1 |
| Torres-Narváez, P | 1 |
| Vega-Martínez, BR | 1 |
| Rojas-Granados, A | 1 |
| Escobar, C | 1 |
| Angeles-Castellanos, M | 1 |
| Huang, YL | 1 |
| Liang, XB | 1 |
| Qian, LQ | 1 |
| Cai, C | 1 |
| Guo, J | 1 |
| Gao, C | 1 |
| Guan, JH | 1 |
| Zhao, GP | 1 |
| Melanson, EL | 1 |
| Higgins, J | 1 |
| Connick, E | 1 |
| Moehlman, TM | 1 |
| Stothard, ER | 1 |
| Wright, KP | 1 |
| Howland, RH | 1 |
| Wang, HR | 1 |
| Woo, YS | 1 |
| Bahk, WM | 1 |
| Wang, S | 1 |
| Jin, X | 1 |
| Kapoor, S | 1 |
| García-Cáceres, C | 1 |
| Diz-Chaves, Y | 1 |
| Lagunas, N | 1 |
| Calmarza-Font, I | 1 |
| Azcoitia, I | 1 |
| Garcia-Segura, LM | 1 |
| Frago, LM | 1 |
| Argente, J | 1 |
| Chowen, JA | 1 |
| García, T | 1 |
| Ribes, D | 1 |
| Colomina, MT | 1 |
| Cabré, M | 1 |
| Domingo, JL | 2 |
| Gómez, M | 2 |
| Salem, AH | 1 |
| Nosseir, NS | 1 |
| El Badawi, MG | 1 |
| Shoair, MI | 1 |
| Fadel, RA | 1 |
| Cizza, G | 1 |
| Requena, M | 1 |
| Galli, G | 1 |
| de Jonge, L | 1 |
| Ross, AW | 1 |
| Helfer, G | 1 |
| Russell, L | 1 |
| Darras, VM | 1 |
| Morgan, PJ | 1 |
| Zhang, L | 1 |
| Zhu, W | 1 |
| Wang, Z | 1 |
| Esparza, JL | 1 |
| Romeu, M | 1 |
| Mulero, M | 1 |
| Sánchez, DJ | 1 |
| Mallol, J | 1 |
| Puchalski, SS | 1 |
| Green, JN | 1 |
| Rasmussen, DD | 2 |
| Prunet-Marcassus, B | 1 |
| Desbazeille, M | 1 |
| Bros, A | 1 |
| Louche, K | 1 |
| Delagrange, P | 1 |
| Renard, P | 1 |
| Casteilla, L | 1 |
| Pénicaud, L | 1 |
| Sener, G | 1 |
| Balkan, J | 1 |
| Cevikbaş, U | 1 |
| Keyer-Uysal, M | 1 |
| Uysal, M | 1 |
| Trivedi, AK | 1 |
| Rani, S | 1 |
| Kumar, V | 1 |
| Taylor, JF | 1 |
| Migaud, H | 1 |
| Porter, MJ | 1 |
| Bromage, NR | 1 |
| Raskind, MA | 1 |
| Burke, BL | 1 |
| Crites, NJ | 1 |
| Tapp, AM | 1 |
| Ritar, AJ | 1 |
| Robertson, JA | 1 |
| Evans, G | 1 |
| Clark, WD | 1 |
| Classen, HL | 1 |
| Imaida, K | 1 |
| Taki, M | 1 |
| Watanabe, S | 1 |
| Kamimura, Y | 1 |
| Ito, T | 1 |
| Yamaguchi, T | 1 |
| Ito, N | 1 |
| Shirai, T | 1 |
| Heideman, PD | 1 |
| Bierl, CK | 1 |
| Sylvester, CJ | 1 |
| Nieminen, P | 1 |
| Käkelä, R | 1 |
| Mustonen, AM | 1 |
| Hyvärinen, H | 1 |
| Asikainen, J | 1 |
| Diekman, MA | 1 |
| Clapper, JA | 1 |
| Green, ML | 1 |
| Stouffer, DK | 1 |
| Porter, JK | 1 |
| Stuedemann, JA | 1 |
| Thompson, FN | 1 |
| Lipham, LB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Comparison of Bupropion SR and Placebo for Smoking Cessation[NCT00176449] | Phase 4 | 52 participants (Actual) | Interventional | 2001-04-30 | Completed | ||
| Multi-scale Modeling of Sleep Behaviors in Social Networks[NCT02846077] | 729 participants (Actual) | Observational | 2013-09-30 | Completed | |||
| Application of a Light/Dark Cycle in Preterm Neonates and Its Association With Shorter In-hospital Stay[NCT05230706] | 300 participants (Actual) | Interventional | 2016-09-10 | Completed | |||
| Behavioral Chronotype: Impact on Sleep and Metabolism[NCT03647306] | 200 participants (Anticipated) | Interventional | 2018-02-02 | Active, not recruiting | |||
| Examining the Impact of a 12-week Worksite Exercise Training Intervention on Mental, Metabolic, Physical, Spiritual, and Occupational Well-being Among Acute Care Nurses: A Randomized, Controlled Mixed Methods Pilot Study[NCT05966805] | 20 participants (Anticipated) | Interventional | 2023-09-13 | Recruiting | |||
| Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia[NCT00595504] | Phase 4 | 25 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Phase 2 Study of Melatonin Adjunct to Olanzapine for Prevention of Olanzapine-associated Metabolic Side Effects.[NCT01593774] | Phase 2 | 36 participants (Actual) | Interventional | 2012-05-31 | Completed | ||
| Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality[NCT00512070] | 20 participants (Anticipated) | Interventional | 2007-07-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A comparison between the ramelteon group and the placebo group of change in abdominal fat measured by a DEXA scan, assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | g (Mean) |
|---|---|
| Ramelteon | 3934.86 |
| Placebo (Sugar Pill) | 5120.92 |
A comparison between the ramelteon group and the placebo group of change in insulin resistance measured by the homeostatic model assessment of insulin resistance (HOMA-IR), assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | HOMA score (Mean) |
|---|---|
| Ramelteon | 2.4 |
| Placebo (Sugar Pill) | 2.36 |
A comparison between the ramelteon group and the placebo group in change in waist circumference (measured in cm) measured at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | cm (Mean) |
|---|---|
| Ramelteon | 106.09 |
| Placebo (Sugar Pill) | 108.37 |
5 reviews available for melatonin and Weight Gain
| Article | Year |
|---|---|
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Topics: Antipsychotic Agents; Betahistine; Famotidine; Fluoxetine; Humans; Melatonin; Metformin; Nausea; Niz | 2022 |
Obesity and sleep disturbance: the chicken or the egg?
Topics: Diet; Endocannabinoids; Energy Metabolism; Exercise; Ghrelin; Humans; Hydrocortisone; Leptin; Melato | 2019 |
Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain.
Topics: Anti-Obesity Agents; Bupropion; Drug Combinations; Humans; Liraglutide; Melatonin; Naltrexone; Obesi | 2015 |
The role of melatonin and melatonin agonists in counteracting antipsychotic-induced metabolic side effects: a systematic review.
Topics: Antioxidants; Antipsychotic Agents; Humans; Indenes; Melatonin; Metabolic Syndrome; Randomized Contr | 2016 |
Chronic sleep deprivation and seasonality: implications for the obesity epidemic.
Topics: Adipose Tissue, Brown; Adult; Aged; Animals; Energy Intake; Energy Metabolism; Female; Hibernation; | 2011 |
4 trials available for melatonin and Weight Gain
| Article | Year |
|---|---|
The Effect of Exogenous Melatonin on Eating Habits of Female Night Workers with Excessive Weight.
Topics: Circadian Rhythm; Eating; Feeding Behavior; Female; Humans; Meals; Melatonin; Sleep; Weight Gain; Wo | 2022 |
Melatonin administration during the dry period stimulates subsequent milk yield and weight gain of offspring in subtropical does kidding in summer.
Topics: Animals; Female; Goats; Lactation; Male; Melatonin; Milk; Photoperiod; Pregnancy; Seasons; Triiodoth | 2019 |
Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Weight; | 2017 |
A light/dark cycle in the NICU accelerates body weight gain and shortens time to discharge in preterm infants.
Topics: Darkness; Heart Rate; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Light | 2014 |
35 other studies available for melatonin and Weight Gain
| Article | Year |
|---|---|
Melatonin protects against body weight gain induced by sleep deprivation in mice.
Topics: Animals; Body Weight; Circadian Rhythm; Melatonin; Mice; Obesity; Sleep; Sleep Deprivation; Weight G | 2022 |
Nano-melatonin and-histidine modulate adipokines and neurotransmitters to improve cognition in HFD-fed rats: A formula to study.
Topics: Adipokines; Animals; Brain-Derived Neurotrophic Factor; Cognition; Diet, High-Fat; Histidine; Melato | 2023 |
Effect of Melatonin Implants and Nutritional Restriction on Growth Performance of Local Male Lambs.
Topics: Animal Feed; Animals; Diet; Eating; Male; Melatonin; Sheep; Weight Gain | 2023 |
Changes in feed consumption and water intake among broiler chickens subjected to melatonin treatment during the hot-dry season.
Topics: Administration, Oral; Analysis of Variance; Animal Feed; Animals; Antioxidants; Chickens; Cost-Benef | 2020 |
Melatonin Orchestrates Lipid Homeostasis through the Hepatointestinal Circadian Clock and Microbiota during Constant Light Exposure.
Topics: Animals; Cell Line; Circadian Clocks; Circadian Rhythm; Dysbiosis; Gastrointestinal Microbiome; Hepa | 2020 |
Effects of Melatonin on Lipid Metabolism and Circulating Irisin in Sprague-Dawley Rats with Diet-Induced Obesity.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Anti-Obesity Agents; Cholesterol; Fibronectin | 2020 |
Long-term melatonin treatment attenuates body weight gain with aging in female mice.
Topics: Adiposity; Aging; Animals; Antioxidants; Female; Melatonin; Mice; Mice, Inbred ICR; Weight Gain | 2021 |
Later circadian timing of food intake is associated with increased body fat.
Topics: Adiposity; Adolescent; Adult; Body Composition; Body Mass Index; Circadian Rhythm; Cohort Studies; C | 2017 |
The effect of agomelatine and melatonin on sleep-related eating: a case report.
Topics: Acetamides; Central Nervous System Depressants; Depressive Disorder, Major; Female; Humans; Melatoni | 2017 |
The study of ameliorative effect of dietary supplementation of vitamin C, vitamin E, and tryptophan on Labeo rohita (Cyprinidae) fry exposed to intense light.
Topics: Animals; Ascorbic Acid; Blood Glucose; Cyprinidae; Dietary Supplements; Energy Metabolism; Glutathio | 2019 |
Melatonin prevents cadmium-induced bone damage: First evidence on an improved osteogenic/adipogenic differentiation balance of mesenchymal stem cells as underlying mechanism.
Topics: Adipocytes; Adipogenesis; Animals; Bone Density; Cadmium; Cell Differentiation; Cell Survival; Male; | 2019 |
Melatonin reduces body weight gain and increases nocturnal activity in male Wistar rats.
Topics: Animals; Blood Glucose; Circadian Rhythm; Darkness; Drinking; Eating; Light; Male; Melatonin; Motor | 2013 |
Effects of Kaixin Powder on melatonin receptor expression and (125)I-Mel binding affinity in a rat model of depression.
Topics: Animals; Brain; Depression; Disease Models, Animal; Drinking Behavior; Drugs, Chinese Herbal; Gene E | 2015 |
Impact of circadian misalignment on energy metabolism during simulated nightshift work.
Topics: Adult; Analysis of Variance; Circadian Rhythm; Eating; Electromyography; Energy Metabolism; Female; | 2014 |
Impact of circadian misalignment on energy metabolism during simulated nightshift work.
Topics: Adult; Analysis of Variance; Circadian Rhythm; Eating; Electromyography; Energy Metabolism; Female; | 2014 |
Impact of circadian misalignment on energy metabolism during simulated nightshift work.
Topics: Adult; Analysis of Variance; Circadian Rhythm; Eating; Electromyography; Energy Metabolism; Female; | 2014 |
Impact of circadian misalignment on energy metabolism during simulated nightshift work.
Topics: Adult; Analysis of Variance; Circadian Rhythm; Eating; Electromyography; Energy Metabolism; Female; | 2014 |
Melatonin prevents obesity through modulation of gut microbiota in mice.
Topics: Animals; Bacteroidetes; Blotting, Western; Central Nervous System Depressants; Diet, High-Fat; Fatty | 2017 |
Strategies to control antipsychotic-induced weight gain.
Topics: Anti-Obesity Agents; Antipsychotic Agents; Awareness; Body Weight; Bupropion; Clinical Competence; F | 2008 |
The weight gain response to stress during adulthood is conditioned by both sex and prenatal stress exposure.
Topics: Age Factors; Animals; Blood Glucose; Castration; Corticosterone; Eating; Female; Hormones; Male; Mel | 2010 |
Evaluation of the protective role of melatonin on the behavioral effects of aluminum in a mouse model of Alzheimer's disease.
Topics: Aluminum Compounds; Alzheimer Disease; Animals; Brain; Diet; Dose-Response Relationship, Drug; Femal | 2009 |
Growth assessment of diabetic rat fetuses under the influence of insulin and melatonin: a morphologic study.
Topics: Animals; Crown-Rump Length; Diabetes Mellitus, Experimental; Female; Fetal Development; Fetal Macros | 2010 |
Thyroid hormone signalling genes are regulated by photoperiod in the hypothalamus of F344 rats.
Topics: Animals; Feeding Behavior; Gene Expression Regulation; Growth Hormone-Releasing Hormone; Hypothalamu | 2011 |
Role of photoperiod on hormone concentrations and adaptive capacity in tree shrews, Tupaia belangeri.
Topics: Adaptation, Physiological; Adipose Tissue, Brown; Animals; Basal Metabolism; Body Composition; Cell | 2012 |
Aluminum-induced pro-oxidant effects in rats: protective role of exogenous melatonin.
Topics: Aluminum; Animals; Antioxidants; Cerebellum; Hematocrit; Hemoglobins; Hippocampus; Lipid Peroxidatio | 2003 |
Melatonin effect on rat body weight regulation in response to high-fat diet at middle age.
Topics: Age Factors; Animals; Circadian Rhythm; Dietary Fats; Eating; Fasting; Insulin; Leptin; Male; Melato | 2003 |
Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity.
Topics: Adipose Tissue; Animals; Blood Glucose; Dietary Fats; Eating; Insulin; Leptin; Male; Melatonin; Obes | 2003 |
Melatonin reduces cholesterol accumulation and prooxidant state induced by high cholesterol diet in the plasma, the liver and probably in the aorta of C57BL/6J mice.
Topics: Animals; Aorta; Cholesterol; Cholesterol, Dietary; Lipid Peroxidation; Liver; Male; Melatonin; Mice; | 2004 |
Melatonin blocks inhibitory effects of prolactin on photoperiodic induction of gain in body mass, testicular growth and feather regeneration in the migratory male redheaded bunting (Emberiza bruniceps).
Topics: Animals; Body Weight; Feathers; Finches; Male; Melatonin; Photoperiod; Prolactin; Regeneration; Test | 2004 |
Photoperiod influences growth rate and plasma insulin-like growth factor-I levels in juvenile rainbow trout, Oncorhynchus mykiss.
Topics: Algorithms; Animals; Female; Growth; Insulin-Like Growth Factor I; Melatonin; Oncorhynchus mykiss; P | 2005 |
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Energy Metabolism; Female; Lipid Meta | 2007 |
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Energy Metabolism; Female; Lipid Meta | 2007 |
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Energy Metabolism; Female; Lipid Meta | 2007 |
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Energy Metabolism; Female; Lipid Meta | 2007 |
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Energy Metabolism; Female; Lipid Meta | 2007 |
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Energy Metabolism; Female; Lipid Meta | 2007 |
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Energy Metabolism; Female; Lipid Meta | 2007 |
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Energy Metabolism; Female; Lipid Meta | 2007 |
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Energy Metabolism; Female; Lipid Meta | 2007 |
Ovulatory activity, hormonal induction of ovulation and fertility of young Cashmere and Angora female goats in a temperate environment.
Topics: Animals; Breeding; Female; Fertility; Goats; Gonadotropins, Equine; Insemination, Artificial; Melato | 1994 |
The effects of continuously or diurnally fed melatonin on broiler performance and health.
Topics: Animals; Chickens; Circadian Rhythm; Eating; Incidence; Linear Models; Male; Melatonin; Poultry Dise | 1995 |
The 1.5 GHz electromagnetic near-field used for cellular phones does not promote rat liver carcinogenesis in a medium-term liver bioassay.
Topics: Adrenocorticotropic Hormone; Animals; Carcinogenicity Tests; Corticosterone; Electromagnetic Fields; | 1998 |
Photoresponsive Fischer 344 Rats are reproductively inhibited by melatonin and differ in 2-[125I] lodomelatonin binding from nonphotoresponsive Sprague-Dawley rats.
Topics: Animals; Autoradiography; Drug Implants; Iodine Radioisotopes; Light; Melatonin; Paraventricular Hyp | 2001 |
Exogenous melatonin affects lipids and enzyme activities in mink (Mustela vison) liver.
Topics: Acid Phosphatase; Animals; Antioxidants; Energy Metabolism; Female; Glucose-6-Phosphatase; Lipid Met | 2001 |
Reduction in age of puberty in gilts consuming melatonin during decreasing or increasing daylength.
Topics: Animals; Estrus; Female; Follicle Stimulating Hormone; Light; Luteinizing Hormone; Melatonin; Season | 1991 |
Neuroendocrine measurements in steers grazed on endophyte-infected fescue.
Topics: Acremonium; Animal Feed; Animals; Cattle; Dopamine; Food Microbiology; Hypothalamus; Male; Melatonin | 1990 |